Does IDURSULFASE Cause Central venous catheterisation? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Central venous catheterisation have been filed in association with IDURSULFASE (ELAPRASE). This represents 0.6% of all adverse event reports for IDURSULFASE.
19
Reports of Central venous catheterisation with IDURSULFASE
0.6%
of all IDURSULFASE reports
1
Deaths
13
Hospitalizations
How Dangerous Is Central venous catheterisation From IDURSULFASE?
Of the 19 reports, 1 (5.3%) resulted in death, 13 (68.4%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which IDURSULFASE Alternatives Have Lower Central venous catheterisation Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB